544 related articles for article (PubMed ID: 24705252)
21. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma.
Cao H; Jin M; Gao M; Zhou H; Tao YJ; Skolnick J
Sci Rep; 2020 Apr; 10(1):6140. PubMed ID: 32273545
[TBL] [Abstract][Full Text] [Related]
22. Design of primers for direct sequencing of nine coding exons in the human ACVR1 gene.
Matsuoka M; Tsukamoto S; Orihara Y; Kawamura R; Kuratani M; Haga N; Ikebuchi K; Katagiri T
Bone; 2020 Sep; 138():115469. PubMed ID: 32512165
[TBL] [Abstract][Full Text] [Related]
23. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.
Wu G; Broniscer A; McEachron TA; Lu C; Paugh BS; Becksfort J; Qu C; Ding L; Huether R; Parker M; Zhang J; Gajjar A; Dyer MA; Mullighan CG; Gilbertson RJ; Mardis ER; Wilson RK; Downing JR; Ellison DW; Zhang J; Baker SJ;
Nat Genet; 2012 Jan; 44(3):251-3. PubMed ID: 22286216
[TBL] [Abstract][Full Text] [Related]
24. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients.
Kaplan FS; Kobori JA; Orellana C; Calvo I; Rosello M; Martinez F; Lopez B; Xu M; Pignolo RJ; Shore EM; Groppe JC
Am J Med Genet A; 2015 Oct; 167A(10):2265-71. PubMed ID: 26097044
[TBL] [Abstract][Full Text] [Related]
25. [A Chinese girl with fibrodysplasia ossificans progressiva caused by a de novo mutation R206H in ACVR1 gene].
Zhou Q; Meng Y; Su L; Zhao SM; Shi HP; Huang SZ
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):215-9. PubMed ID: 19099712
[TBL] [Abstract][Full Text] [Related]
26. Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish.
Allen RS; Tajer B; Shore EM; Mullins MC
Elife; 2020 Sep; 9():. PubMed ID: 32897189
[TBL] [Abstract][Full Text] [Related]
27. Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting.
Nagar G; Mittal P; Gupta SRR; Pahuja M; Sanger M; Mishra R; Singh A; Singh IK
Brief Funct Genomics; 2023 Apr; 22(2):123-142. PubMed ID: 36003055
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.
Mohedas AH; Wang Y; Sanvitale CE; Canning P; Choi S; Xing X; Bullock AN; Cuny GD; Yu PB
J Med Chem; 2014 Oct; 57(19):7900-15. PubMed ID: 25101911
[TBL] [Abstract][Full Text] [Related]
29. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call.
Towler OW; Shore EM; Xu M; Bamford A; Anderson I; Pignolo RJ; Kaplan FS
Eur J Med Genet; 2017 Jul; 60(7):399-402. PubMed ID: 28473268
[TBL] [Abstract][Full Text] [Related]
30. ACVR1 gene mutations in four Turkish patients diagnosed as fibrodysplasia ossificans progressiva.
Eresen Yazıcıoğlu C; Karatosun V; Kızıldağ S; Ozsoylu D; Kavukçu S
Gene; 2013 Feb; 515(2):444-6. PubMed ID: 23260810
[TBL] [Abstract][Full Text] [Related]
31. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.
Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN
Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737
[TBL] [Abstract][Full Text] [Related]
32. BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).
Towler OW; Shore EM
Dev Dyn; 2022 Jan; 251(1):164-177. PubMed ID: 34133058
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements.
Bocciardi R; Bordo D; Di Duca M; Di Rocco M; Ravazzolo R
Eur J Hum Genet; 2009 Mar; 17(3):311-8. PubMed ID: 18830232
[TBL] [Abstract][Full Text] [Related]
34. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.
Shore EM; Xu M; Feldman GJ; Fenstermacher DA; Cho TJ; Choi IH; Connor JM; Delai P; Glaser DL; LeMerrer M; Morhart R; Rogers JG; Smith R; Triffitt JT; Urtizberea JA; Zasloff M; Brown MA; Kaplan FS
Nat Genet; 2006 May; 38(5):525-7. PubMed ID: 16642017
[TBL] [Abstract][Full Text] [Related]
35. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant.
Haupt J; Deichsel A; Stange K; Ast C; Bocciardi R; Ravazzolo R; Di Rocco M; Ferrari P; Landi A; Kaplan FS; Shore EM; Reissner C; Seemann P
Hum Mol Genet; 2014 Oct; 23(20):5364-77. PubMed ID: 24852373
[TBL] [Abstract][Full Text] [Related]
36. A recurrent mutation c.617G>A in the ACVR1 gene causes fibrodysplasia ossificans progressiva in two Chinese patients.
Sun Y; Xia W; Jiang Y; Xing X; Li M; Wang O; Zhang H; Hu Y; Liu H; Meng X; Zhou X
Calcif Tissue Int; 2009 May; 84(5):361-5. PubMed ID: 19300893
[TBL] [Abstract][Full Text] [Related]
37. Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva.
Song GA; Kim HJ; Woo KM; Baek JH; Kim GS; Choi JY; Ryoo HM
J Biol Chem; 2010 Jul; 285(29):22542-53. PubMed ID: 20463014
[TBL] [Abstract][Full Text] [Related]
38. Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1
Wentworth KL; Lalonde RL; Groppe JC; Brewer N; Moody T; Hansberry S; Taylor KE; Shore EM; Kaplan FS; Pignolo RJ; Yelick PC; Hsiao EC
J Bone Miner Res; 2022 Nov; 37(11):2058-2076. PubMed ID: 36153796
[TBL] [Abstract][Full Text] [Related]
39. Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1.
Aykul S; Huang L; Wang L; Das NM; Reisman S; Ray Y; Zhang Q; Rothman N; Nannuru KC; Kamat V; Brydges S; Troncone L; Johnsen L; Yu PB; Fazio S; Lees-Shepard J; Schutz K; Murphy AJ; Economides AN; Idone V; Hatsell SJ
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35511419
[TBL] [Abstract][Full Text] [Related]
40. The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva.
Nakajima M; Haga N; Takikawa K; Manabe N; Nishimura G; Ikegawa S
J Hum Genet; 2007; 52(5):473-475. PubMed ID: 17351709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
